GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
Set alert
2,508.70 INR -6.40 -0.25%
As of Oct 30, 6:00 AM ET
2,479.30 Day range 2,528.90
2,088.10 52-week range 3,120.70
- YTD
- +2.15%
- 1 year
- -4.20%
- Open
- 2,527.60
- Prev close
- 2,515.10
- Mkt cap
- 424.99B
- Vol
- 56.35K
- Avg vol
- 104.14K
- EPS
- 63.05
- P/E
- 39.79
- Div yield
- 0.00%
More statistics
- Low
- 2,479.30
- High
- 2,528.90
1Y chart
Signals (45)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 3 days ago |
| RSI: Oversold | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 18, 2026 | 1 week ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| RSI: Overbought | Aug 23, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 16, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| RSI: Overbought | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 19, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 16, 2026 | 4 months ago |
| RSI: Oversold | Jun 10, 2026 | 4 months ago |
| RSI: Oversold | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 17, 2026 | 5 months ago |
| MACD: Sell Signal | May 17, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 26, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 7, 2026 | 6 months ago |
| RSI: Oversold | Mar 22, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| RSI: Overbought | Feb 10, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 27, 2026 | 9 months ago |
| RSI: Oversold | Jan 19, 2026 | 9 months ago |
| RSI: Oversold | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 12, 2025 | 11 months ago |
| RSI: Oversold | Nov 9, 2025 | 11 months ago |
Compare GLAXO.NS
Chart and line up GLAXO.NS against other symbols or a saved comparison set.
- GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,508.70
-6.40 -0.25%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | GLAXO.NS | SPY | QQQ |
|---|---|---|---|
| Last price | 2,508.70 | 755.72 | 690.49 |
| Change | -6.40 | -13.64 | -24.85 |
| Change % | -0.254463% | -1.77% | -3.47% |
| Open | 2,527.60 | 761.38 | 697.13 |
| Day high | 2,528.90 | 761.46 | 698.63 |
| Day low | 2,479.30 | 750.36 | 683.45 |
| Previous close | 2,515.10 | 769.36 | 715.34 |
| Volume | 56.35K | 77.70M | 85.24M |
| Average volume | 104.14K | 41.22M | 34.57M |
| Market cap | 424.99B | 812.08B | 483.28B |
| P/E ratio | 39.79 | 23.99 | 26.44 |
| Earnings per share | 63.05 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 3,120.70 | 779.09 | 759.66 |
| 52-week low | 2,088.10 | 631.97 | 558.28 |
| 1-week return | +4.32% | -0.559233% | -1.97% |
| 1-month return | -9.47% | -0.906075% | -6.66% |
| 3-month return | -5.52% | +1.89% | +1.02% |
| 6-month return | +7.37% | +5.16% | +3.41% |
| Year-to-date return | +2.15% | +10.82% | +12.40% |
| 1-year return | -4.20% | +11.16% | +10.29% |
| 2-year return | -7.50% | +32.90% | +42.71% |
| 50-day moving average | 2,748.95 | 767.63 | 725.41 |
| 200-day moving average | 2,518.73 | 728.53 | 679.17 |
| Target price | — | — | — |
| Beta | 0.00 | 0.00 | 0.00 |
| Short ratio | — | — | — |
| Institutional ownership | 0.00% | — | — |